Perfect Medical (01830.HK) released an announcement on June 28th stating that for the fiscal year ending on March 31st, 2024, revenues increased by 0.3% to HKD 1.393 billion; profit before interest, taxes, and property, plant and equipment depreciation decreased by 4.4% to HKD 461 million; profit attributable to equity holders of the company (excluding Hong Kong government subsidies) increased by 6.8% to HKD 316 million; basic earnings per share remained at 25.1 Hong Kong cents; recommended final and special dividends are 11.9 Hong Kong cents and 5.4 Hong Kong cents per share, a total of 17.3 Hong Kong cents per share, and the annual dividend is 31.5 Hong Kong cents per share. The annual dividend payout ratio is 125.5%, with the group maintaining a dividend payout ratio of 100% or higher for nine consecutive years.
Looking back at the fiscal year, despite the slowdown in consumer demand, the group still delivered steady performance. The group achieved sales contract prices of HKD 1.446 billion, a year-on-year decrease of 0.3%. Group revenue increased by 0.3% year-on-year to HKD 1.393 billion (fiscal year 2022/23: HKD 1.389 billion), benefiting from the recovery of consumer demand and the contribution of new stores in Hong Kong and mainland China. In this fiscal year, the medical beauty business continued to be the core business of the group, contributing approximately 81.8% of the sales contract value. The average annual consumption per medical beauty customer increased by 2.7% to HKD 28,784.